Furthermore, ISO treatment stimulates the expression of several chemokines, including CXCL2, CXCL3, CXCL4, CXCL6, CXCL10, CXCL11, and CCL5. These chemokines can recruit anti-tumor immune cells [108]. The gene discussed is CXCL10; the disease is neoplasm.